(NASDAQ: SEER) Seer's forecast annual revenue growth rate of 36.41% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.17%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Seer's revenue in 2025 is $14,170,000.On average, 2 Wall Street analysts forecast SEER's revenue for 2025 to be $1,044,810,626, with the lowest SEER revenue forecast at $1,044,392,151, and the highest SEER revenue forecast at $1,045,229,100. On average, 2 Wall Street analysts forecast SEER's revenue for 2026 to be $1,523,365,816, with the lowest SEER revenue forecast at $1,375,823,753, and the highest SEER revenue forecast at $1,670,907,878.
In 2027, SEER is forecast to generate $2,179,832,342 in revenue, with the lowest revenue forecast at $1,863,824,505 and the highest revenue forecast at $2,495,899,961.